Welcome to LookChem.com Sign In|Join Free

CAS

  • or
[1,1'-Biphenyl]-4-ol,2'-(2H-tetrazol-5-yl)is a chemical compound characterized by its unique structure, featuring a biphenyl ring with a hydroxyl group at the 4th position and a 2H-tetrazol-5-yl group at the 2' position. [1,1'-Biphenyl]-4-ol,2'-(2H-tetrazol-5-yl)may exhibit potential biological activities and holds promise for applications in the pharmaceutical and medicinal chemistry fields.

150368-30-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 150368-30-2 Structure
  • Basic information

    1. Product Name: [1,1'-Biphenyl]-4-ol,2'-(2H-tetrazol-5-yl)-
    2. Synonyms: [1,1'-Biphenyl]-4-ol,2'-(1H-tetrazol-5-yl)- (9CI); 4-[2-(1H-Tetrazol-5-yl)phenyl]phenol
    3. CAS NO:150368-30-2
    4. Molecular Formula: C13H10 N4 O
    5. Molecular Weight: 238.249
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 150368-30-2.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: [1,1'-Biphenyl]-4-ol,2'-(2H-tetrazol-5-yl)-(CAS DataBase Reference)
    10. NIST Chemistry Reference: [1,1'-Biphenyl]-4-ol,2'-(2H-tetrazol-5-yl)-(150368-30-2)
    11. EPA Substance Registry System: [1,1'-Biphenyl]-4-ol,2'-(2H-tetrazol-5-yl)-(150368-30-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 150368-30-2(Hazardous Substances Data)

150368-30-2 Usage

Uses

Used in Pharmaceutical Industry:
[1,1'-Biphenyl]-4-ol,2'-(2H-tetrazol-5-yl)is used as a potential pharmaceutical compound for its possible biological activities and unique structural properties. [1,1'-Biphenyl]-4-ol,2'-(2H-tetrazol-5-yl)-'s specific application reason is yet to be determined, but its structure suggests it may have potential in the development of new drugs or therapies.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, [1,1'-Biphenyl]-4-ol,2'-(2H-tetrazol-5-yl)is used as a compound with potential for the development of novel therapeutic agents. Its unique structure may allow for the creation of new drugs that target specific biological pathways or interact with certain proteins, offering new treatment options for various medical conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 150368-30-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,3,6 and 8 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 150368-30:
(8*1)+(7*5)+(6*0)+(5*3)+(4*6)+(3*8)+(2*3)+(1*0)=112
112 % 10 = 2
So 150368-30-2 is a valid CAS Registry Number.

150368-30-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[6-(1,2-dihydrotetrazol-5-ylidene)cyclohexa-2,4-dien-1-ylidene]cyclohexa-2,5-dien-1-one

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:150368-30-2 SDS

150368-30-2Relevant articles and documents

Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: Synthesis, biological properties, and structure-activity relationships

Kyoung Soon Kim,Qian,Bird,Dickinson,Moreland,Schaeffer,Waldron,Delaney,Weller,Miller

, p. 2335 - 2342 (2007/10/02)

A series of novel quinoxaline heterocycle containing angiotensin II receptor antagonist analogs were prepared. This heterocycle was coupled to the biphenyl moiety via an oxygen atom linker instead of a carbon atom. Many of these analogs exhibit very poten

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 150368-30-2